RADAR-CNS: Remote Assessment of Disease and Relapse – Central Nervous System
A collaborative research programme that explored the potential of wearable devices to help measure and predict clinical outcomes in depression, MS and epilepsy
RADAR-CNS
A collaborative research programme that explored the potential of wearable devices to help measure and predict clinical outcomes in depression, MS and epilepsy
RADAR-CNS was a major new research programme that developed new ways of monitoring major depressive disorder, epilepsy, and multiple sclerosis using wearable devices and smartphone technology.
RADAR-CNS was jointly led by King’s College London and Janssen Pharmaceutica NV, funded by the Innovative Medicines Initiative (a Public Private Partnership established between the European Federation of Pharmaceutical Industries and Associations (EFPIA) and the European Union) and involved 22 organisations from across Europe and the US. The programme ran from 2016 to 2022.
-
Paving the way for use of remote measurement technology in healthcare
The results of the six-year long RADAR-CNS programme have provided landmark insights into how wearables and smartphones could transform how we monitor and manage depression, multiple sclerosis (MS) and epilepsy. -
RADAR-CNS Videos
Watch interviews with our researchers and members of our Patient Advisory Board. These videos document our processes and results across the different work streams, including research on use of wearables and smartphones in depression, Multiple Sclerosis and epilepsy. -
Explore our infographic to find out more about the results and insights
Our infographic highlights key findings across the different work streams. This includes research on use of wearables and smartphones in three conditions, as well as the work to transform data into signals that could help monitor and manage these conditions.